CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,806 | $558.31 | $1.0M | 43,913 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −922 | $559.41 | $516K | 42,991 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −558 | $560.10 | $313K | 42,433 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $561.51 | $292K | 41,913 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −402 | $562.54 | $226K | 41,511 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −716 | $563.38 | $403K | 40,795 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −122 | $564.22 | $69K | 40,673 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $566.00 | $91K | 40,513 |
| 2026-04-06 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 2,500 | ||
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −40 | $551.86 | $22K | 28,836 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −401 | $553.99 | $222K | 28,435 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −778 | $555.22 | $432K | 27,657 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −844 | $556.17 | $469K | 26,813 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −977 | $557.05 | $544K | 25,836 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −720 | $558.11 | $402K | 25,116 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −240 | $559.03 | $134K | 24,876 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −72 | $560.39 | $40K | 24,804 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −571 | $561.75 | $321K | 24,233 |
| 2026-04-02 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −555 | $563.00 | $312K | 23,678 |
Page 130 of 171 · 3,408 trades